Stay updated with breaking news from Synlogic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates - Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023... | March 29, 2023
– Phenylketonuria program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934 for PKU and... | March 29, 2023
– Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934...
Item 2.02 Results of Operations and Financial Condition. On March 29, 2023, Synlogic, Inc. announced its financial results for the quarter and full year ended December 31, 2022. The full text of the... | March 29, 2023
Analysts’ updated eps estimates for Wednesday, March 29th: Boliden AB (publ) (OTCMKTS:BDNNY) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating. Robert W. Baird began coverage on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX). Robert W. Baird issued an outperform rating on the stock. Mizuho assumed coverage on shares of […]